Fresh data from multiple studies suggest the drug, which Sanofi has billed as a future blockbuster, could be cleared in the U ...
I think there’s common ground here,” one Republican congressman said Wednesday during a House Budget Committee hearing.
Novo shares have surged more than 20% amid oral Wegovy’s fast start. Elsewhere, Terns opened up room for a potential ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback